Search Results

For in vitro diagnostic use: Etest is a quantitative technique for the determination of antimicrobial susceptibility of both non-fastidious Gram negative and Gram positive aerobic bacteria, such as Enterobacteriaceae, Pseudomonas, Staphylococcus and Enterococcus species and fastidious bacteria, such as anaerobes, Pneumococcus and Haemophilus species. The system comprises a predefined antibiotic gradient which is used to determine the Minimum Inhibitory Concentration (MIC) in µg/ml of individual antibiotics against bacteria as tested on agar media by overnight incubation. This Etest 510(k) application is for MIC determination of Ciprofloxacin in the range of 0.002 - 32 µg/ml with non-fastidious Gram negative and Gram positive aerobic bacteria, and N. gonorrhoeae.

Not Found

The provided document does not contain information regarding specific acceptance criteria, a study proving device performance against those criteria, or details regarding sample sizes, expert qualifications, or ground truth establishment.

The document is a 510(k) clearance letter from the FDA for the "Etest Ciprofloxacin" device, dated June 2, 1998. It confirms that the device is substantially equivalent to legally marketed predicate devices for its stated indications for use.

The "Indications For Use" section on page 2 describes what the device does: "Etest is a quantitative technique for the determination of antimicrobial susceptibility of both non-fastidious Gram negative and Gram positive aerobic bacteria, such as Enterobacteriaceae, Pseudomonas, Staphylococcus and Enterococcus species and fastidious bacteria, such as anaerobes, Pneumococcus and Haemophilus species. The system comprises a predefined antibiotic gradient which is used to determine the Minimum Inhibitory Concentration (MIC) in µg/ml of individual antibiotics against bacteria as tested on agar media by overnight incubation. This Etest 510(k) application is for MIC determination of Ciprofloxacin in the range of 0.002 - 32 µg/ml with non-fastidious Gram negative and Gram positive aerobic bacteria, and N. gonorrhoeae."

However, this section does not include:

1. A table of acceptance criteria and reported device performance.
2. Sample sizes or data provenance for a test set.
3. Number or qualifications of experts for ground truth.
4. Adjudication method.
5. MRMC comparative effectiveness study details.
6. Standalone performance details.
7. Type of ground truth used.
8. Sample size for the training set.
9. How ground truth for the training set was established.

Therefore, I cannot fulfill the request to describe the acceptance criteria and the study that proves the device meets the acceptance criteria with the information given in the provided document. This document is a regulatory approval letter, not a detailed study report.

Ask a specific question about this device